A.I.R
LIVE

Serial Number

87024815

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

May 4, 2016

Add to watchlist:

No watchlists yet
View on USPTO

A.I.R Trademark

Serial Number: 87024815 • Registration: 6481284

A.I.R is a trademark filed by BioNTech SE on May 4, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BIONTECH RNA PHARMACEUTICALS GMBH (12 trademarks)

AN DER GOLDGRUBE 12
55131 MAINZ 60430 , DE

Entity Type: 16

Trademark Details

Filing Date

May 4, 2016

Registration Date

September 14, 2021

Published for Opposition

June 29, 2021

Goods & Services

Human and veterinary pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, and immunological diseases, in particular by way of nucleic acids, amplifying nucleic acids, viruses, viral like particles, peptides and proteins

Pharmaceutical and veterinary information leaflets; Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters for providing medical, pharmaceutical, and scientific research information

Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines, in particular nucleic acids, amplifying nucleic acids, peptides and proteins for laboratory use

Medical services, in particular, providing therapies and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; Veterinary services, in particular, providing therapies and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; Medical, veterinary and pharmaceutical consultation; Medical and veterinary diagnostic testing, monitoring and reporting services

Providing scientific research information, consultancy, and advisory services, namely, medical research information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases for humans or animals; Providing medical research information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Oct 15, 2024 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 6, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 5, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Feb 28, 2024 ES7R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 22, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 22, 2024 COAR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 6, 2021 ASCK
REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 29, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 23, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 27, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 27, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jan 27, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2021 CRFA
ASSIGNED TO LIE
Dec 29, 2020 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 23, 2020 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 1, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 11, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 28, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 5, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 1, 2018 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 23, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 23, 2017 GNSL
SUSPENSION LETTER WRITTEN
Oct 23, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2017 CRFA
ASSIGNED TO LIE
Mar 13, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2016 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 21, 2016 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 21, 2016 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2016 NWOS
NEW APPLICATION ENTERED
May 7, 2016 NWAP